Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells

J Immunol. 2001 Mar 1;166(5):3130-42. doi: 10.4049/jimmunol.166.5.3130.

Abstract

The mechanism underlying apoptosis induced by proteasome inhibition in leukemic Jurkat and Namalwa cells was investigated in this study. The proteasome inhibitor lactacystin differentially regulated the protein levels of proapoptotic Bcl-2 family members and Bik was accumulated at the mitochondria. Bik overexpression sufficed to induce apoptosis in these cells. Detailed examination along the respiration chain showed that lactacystin compromised a step after complex III, and exogenous cytochrome c could overcome this compromise. Probably as a result, the succinate-stimulated generation of mitochondrial membrane potential was significantly diminished. Bcl-x(L) interacted with Bik in the cells, and Bcl-x(L) overexpression prevented cytochrome c leakage out of the mitochondria, corrected the mitochondrial membrane potential defect, and protected the cells from apoptosis. These results show that proteasomes can modulate apoptosis of lymphocytes by affecting the half-life of Bcl-2 family members, Bik being one of them.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / analogs & derivatives*
  • Acetylcysteine / pharmacology
  • Amino Acid Chloromethyl Ketones / pharmacology
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / immunology*
  • Apoptosis Regulatory Proteins
  • Cysteine Endopeptidases / metabolism
  • Cysteine Endopeptidases / physiology*
  • Cysteine Proteinase Inhibitors / pharmacology
  • Cytochrome c Group / metabolism
  • Electron Transport / drug effects
  • Electron Transport / immunology
  • Enzyme Activation / drug effects
  • Enzyme Activation / immunology
  • Humans
  • Intracellular Membranes / enzymology
  • Intracellular Membranes / immunology
  • Jurkat Cells
  • Leukemia, B-Cell / enzymology*
  • Leukemia, B-Cell / immunology
  • Leukemia, B-Cell / metabolism
  • Leukemia, B-Cell / pathology*
  • Leukemia, T-Cell / enzymology*
  • Leukemia, T-Cell / immunology
  • Leukemia, T-Cell / metabolism
  • Leukemia, T-Cell / pathology*
  • Membrane Potentials / immunology
  • Membrane Proteins*
  • Mitochondria / enzymology
  • Mitochondria / immunology
  • Mitochondrial Proteins
  • Multienzyme Complexes / antagonists & inhibitors
  • Multienzyme Complexes / metabolism
  • Multienzyme Complexes / physiology*
  • Peptide Hydrolases / metabolism
  • Permeability
  • Proteasome Endopeptidase Complex
  • Protein Biosynthesis
  • Proteins / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Proto-Oncogene Proteins c-bcl-2 / physiology
  • Rats
  • Tumor Cells, Cultured
  • bcl-X Protein

Substances

  • Amino Acid Chloromethyl Ketones
  • Apoptosis Regulatory Proteins
  • BCL2L1 protein, human
  • BIK protein, human
  • Bcl2l1 protein, rat
  • Cysteine Proteinase Inhibitors
  • Cytochrome c Group
  • Membrane Proteins
  • Mitochondrial Proteins
  • Multienzyme Complexes
  • Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-X Protein
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • lactacystin
  • Peptide Hydrolases
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex
  • DEVDase
  • Acetylcysteine